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Objective.The nephron (pro)renin receptor may play a pathophysiological role in renal disorders in hypertension or diabetes. The
aim of this study was to determine the relationship of (pro)renin receptors and transdifferentiation between the renin-negative and
renin-positive SMCs in the afferent arteriole by estimating the distribution of (pro)renin receptors in renin-positive and renin-
negative SMCs of the afferent arteriole of kidneys in normal and streptozotocin- (STZ-) induced diabetic rats.Therefore in diabetes
the renin granulation of afferent arterioles is different as in normal, the diabetes model for finding the differences to normal in
distribution of (pro)renin receptors of afferent arterioles was used. Method. To estimate the number of (pro)renin receptors in
arteriolar SMCs a special protocol of immunohistochemistry to stereology was followed. Results. Our results showed that on the
surface of renin-positive SMCs the number of (pro)renin receptors was upregulated, while in the cytoplasm of SMCs there was
downregulation in comparison to renin-negative SMCs.There is a significant difference between the number of (pro)renin receptors
on the surface and in the cytoplasm of renin-positive SMCs in normal rats.These differences in the number of (pro)renin receptors
were not present in rats with STZ-induced diabetes. Any other differences in the number of (pro)renin receptors between the STZ-
induced diabetic and normal rats were not detected.The tissue level of angiotensin II did not change in the kidneys of STZ-induced
diabetic rats. Conclusion. The distribution of (pro)renin receptors in afferent arteriolar SMCs is related to renin granulation of
SMCs, but independent of angiotensin II plasma or tissue levels in the kidney.
1. Introduction
The intrarenal renin-angiotensin system (RAS) controls the
glomerular filtration rate through glomerular fluid flow and
pressure. Systematically circulated renin is synthesized by
renin-positive smooth muscle cells (SMCs) of the afferent
arteriole and tubule in normal and diabetic rats [1–3].
Renin synthesis in SMCs of afferent arterioles is related to
angiotensin II via the angiotensin II receptors [4–6]. The
transdifferentiation between the renin-positive and renin-
negative SMCs of afferent arterioles in rat kidney is depen-
dent on the number of AT1(A) receptors that are active in the
RAS of SMCs [5, 6], similarly to transdifferentiation between
the macula densa and tubular cells [7]. The distribution of
angiotensin II receptors (AT1(A) and AT1(B)) in rat kidneys
differs significantly between normal and STZ-induced dia-
betes. These changes were related to the renin positivity of
afferent arterioles and independent of the intrarenal levels of
angiotensin II in diabetic rats [6].
The receptor binding renin and (pro)renin, termed as the
(pro)renin receptor, was cloned in 2002 [8]. The (pro)renin
receptor has been localized in glomerular mesangial cells
and in vascular smooth muscle cells of renal arteries and
coronary arteries. It was also found in glomerular epithelial
cells and in distal and collecting tubular cells of the kidney [9].
The (pro)renin receptors are highly expressed in developing
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mouse kidney. In human neonates, the enhanced expression
of renal (pro)renin receptors was also detected. These data
support the hypothesis that (pro)renin receptors regulate
kidney development [10].
The nephron (pro)renin receptor may play a pathophys-
iological role in renal disorders in hypertension or diabetes
[11].The function of (pro)renin receptors as potential positive
regulators in intrarenal RAS has been shown, although it
remains to be determinedwhether prorenin and renin are the
true physiological ligand of the (pro)renin receptor [12].
The aim of this study is to determine the relationship of
(pro)renin receptors and renin granulation in SMCs in the
afferent arteriole by estimating the distribution of (pro)renin
receptors in renin-positive and renin-negative SMCs of the
afferent arteriole in kidneys of normal and STZ-induced
diabetic rats.
2. Materials and Method
The induction of diabetes with streptozotocin (STZ) in rats
and themeasurement of angiotensin II levels were carried out
following a previously described protocol [6].
Animals with STZ-Induced Diabetes. STZ (Sigma, USA) was
administered intraperitoneally at a dose of 60 mg/kg to adult
male Wistar rats (300-400 g; n=5). After 48 h, blood sugar
levels were measured; animals in which the blood sugar level
exceeded 18 mM were regarded as diabetic. The blood sugar
level and the weight of the animals were followed over a
period of 10 weeks, after which the rats were killed.
The Measurement of Angiotensin II Levels. Following the
streptozotocin treatment, blood samples were added by
phlebotomy from the vena cava posterior into Vacutainer
EDTA tubes, while after laparotomy the kidneys were excised
and purified from adipose tissue. The high-sensitivity Uscn
Life Science Inc. ELISA kit (Cat.no.US-E90005Ra) was used
to determine the level of angiotensin II in blood and kidney
tissue samples. The tissue and blood were prepared in strict
accordance with instructions in the user manual of the kit.
Immunohistochemistry. For immunohistochemical purposes,
the same protocol was performed as described earlier [13].
Sections placed on glass slides were washed in PBS (pH =
7.4) for 10 min and then incubated in normal rabbit serum
1:100 (EMS, USA) in PBS (pH = 7.4) for 20 min. The primary
antibody against the renin receptor (K-19; sc55025, Santa
Cruz Biotechnology, INC; USA) was diluted 1:50 in PBS (pH
= 7.4) and left overnight at 4∘C in a wetting chamber. The
sectionswere subsequently washed three times for 5min each
in PBS (pH = 7.4). 0.8-nm gold-conjugated rabbit-anti-goat
IgG (Aurion Immunogold; EMS, USA) was diluted 1:100 in
PBS (pH= 7.4), allowed to stand for 2 h and thenwashed three
times for 5 min each in PBS (pH = 7.4). The sections were
fixed with 3% glutaraldehyde in PBS (pH = 7.4) and washed
with distilledwater for 5min, followed by silver enhancement
with Danscher solution (Aurion R-Gent SE-EM; EMS, USA)
for 75 min at 25∘C, resulting in a particle size around 30 nm.
Finally, the sections were washed three times for 5 min each
with distilled water.
Background Noise of the Immunohistochemistry. The quality
of the immunohistochemical signal at the electron micro-
scope level is crucial for unbiased results. For immunohis-
tochemistry, the (pro)renin receptor (K-19; sc55025, Santa
Cruz Biotechnology, INC; USA) was used as the pri-
mary antibody, where background-less staining was guar-
anteed by recombinant technology in the preparation
of this reagent. The noise of the labeling system was
tested without primary antibody; the use of normal rabbit
serum for blocking was sufficient for noiseless staining
[13].
Embedding and Sectioning. The immunostained serial sec-
tions were placed on glass slides and dehydrated with an
ordinary series of ethanol and acetone and infiltrated for
10 min with epoxy resin (Embed 812; EMS, USA). The
sections were then capped with plastic capsules filled with
clean resin. The semithin (0.4-𝜇m) and thin (70+/-5-nm;
mean+/-SD) sections were prepared with an Ultracut S
(Leica) ultramicrotome. The thin sections were stained with
uranyl acetate and lead citrate.
Stereology. For sampling, the previously described protocol
was followed [13]. An afferent arteriole was defined as a
preglomerular arteriole from the glomerulus to the first
branching. An efferent arteriole was defined as a post-
glomerular arteriole from the glomerulus to the capillary.
Each arteriole was followed on a series of semithin sections,
and profiles appearing from the same arteriole were identified
[14, 15]. The TEM micrographs were prepared with JEM-
1400 plus electron microscope (JEOL, Peabody, MA, USA).
The immunohistochemical signals of the renin receptor
molecules were counted on the surface and in the cytoplasm
of arteriolar SMCs, renin-granulated cells, and endothelial
cells and on renin granules of afferent and efferent arterioles.
More details can be found in articles by Razga andNyengaard
[4, 5].
Statistics. For the comparison of differences between the two
groups, Student’s t-test was applied.
3. Results
3.1. Diabetic Animals. The STZ treatment was successful: the
blood sugar levels of the animals increased 3-fold by the end
of 10 weeks (Table 1).
3.2.Morphology ofDiabetic Kidney. Therewere not found any
secondary pathomorphological changes in glomerulus and
increments in renin granulation of arterioles.
3.3. The Angiotensin II Levels in the Plasma and the Kidney.
Therewere no significant differences between the angiotensin
II levels of the plasma or the kidney in the controls and
diabetic rats after the 10-week STZ treatment (Table 2).
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Table 1: Changes in blood sugar level and body weight following the STZ diabetic protocol.
Animal weight (g) Blood sugar level (mM/l)
mean mean SD
Control start n=4 354 6.7 0.43
10 weeks n=4 457 5.53 0.86
Diabetic start n=5 360 6.25 0.49
10 weeks n=5 318 20.25 9.68
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Figure 1: The number of renin receptors on the surface of afferent arteriolar SMCs.
Table 2: Angiotensin II levels in the plasma and the kidney (pg/ml).
Control Diabetes
n mean (CV) mean (CV)
Angiotensin II
plasma level
(pg/ml)
3 270(0.56) 246(0.29) NS
Angiotensin II
kidney level
(pg/ml)
3 666(0.02) 668(0.04) NS
3.4. Immunohistochemical Signal of Renin Receptors in Arte-
rioles. The immunohistochemical signal of renin was found
on the surface and in the cytoplasm of renin-positive and
renin-negative SMCs of afferent arterioles. The signal was
also present in renin vacuoles and on the surface of arteriolar
endothelial cells (Figure 3).
3.5. Distribution of Renin Receptors in Arterioles. Our results
showed no significant differences in the relative num-
ber of (pro)renin receptors in renin-positive and renin-
negative SMCs of arterioles between the normal and diabetic
rats, excluding the efferent arteriolar renin-negative SMCs
(Table 3). The relative number of (pro)renin receptors in
renin granules or on the surface of endothelial cells did not
show significant differences between normal and diabetic rats
(Table 4).
There were significant differences in the relative num-
ber of (pro)renin receptors between the surfaces of renin-
negative and renin-positive SMCs of afferent arterioles in
kidneys of normal rats (Figure 1). Also, significant differences
were found in the relative number of (pro)renin receptors
between the cytoplasm of renin-negative and renin-positive
SMCs of afferent arterioles in kidneys of normal rats (Fig-
ure 2), while significant differences in the relative number of
(pro)renin receptors on surfaces and in cytoplasm in STZ-
induced diabetic rats were not present (Figures 1 and 2).
Significant differences in the relative number of
(pro)renin receptors between the cytoplasm and the
surface of renin-positive SMCs were only found in the
afferent arterioles of normal rats; in any other SMCs, no
significant differences were found between the cytoplasm
and the surface (Table 5).
4. Discussion
The main issue of this study is whether the (pro)renin
receptors could be involved in the intrarenal RAS, that is,
whether the renin granulation of SMCs could be changed
through the (pro)renin receptors.
In STZ-induced diabetes, renin granulation in the afferent
arteriole is higher than normal, while angiotensin II levels
in the kidney are also elevated [1, 2, 16, 17]. Earlier investi-
gations clarified this discrepancy, where the heterogeneous
regulation of angiotensin II receptors as AT1A and AT1B was
presented [6]. The special physiological/pathophysiological
4 International Journal of Nephrology
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Figure 2: The number of renin receptors in the cytoplasm of afferent arteriolar SMCs.
Table 3: The number of renin receptors in renin positive and renin negative SMCs in normal and diabetic rats.
n normal diabetic p
mean (CV)
renin receptor in afferent arterioles cell surface (signals/𝜇m3) Renin-positive SMCs 5 0.66(0.37) 1.02 (0.68) NS
Renin-negative SMCs 5 0.34(0.43) 0.61(0.76) NS
renin receptor in efferent arterioles cell surface (signals/𝜇m3) Renin-negative SMCs 5 0.42(0.78) 0.99(0.59) 0.047
renin receptor in afferent arterioles cell cytoplasm (signals/𝜇m3) Renin-positive SMCs 5 1.3(0.34) 0.79(0.61) NS
Renin-negative SMCs 5 0.62(0.66) 1.09(0.81) NS
state of renin granulation in STZ-induced diabetes has
turned attention towards estimating the number (pro)renin
receptors in STZ-induced diabetic rats. The distribution of
(pro)renin receptors in normal arterioles of the kidney was
not examined earlier.
In this study, the estimation of the number of (pro)renin
receptors in arteriolar SMCs showed a significant difference
between renin-positive and renin-negative SMCs (the surface
and cytoplasm) in normal rat kidneys. On the surface of
renin-positive SMCs, the number of (pro)renin receptors
was upregulated, while in the cytoplasm of SMCs there was
downregulation compared to renin-negative SMCs (Figures 1
and 2.). Between the surface and cytoplasm of renin-positive
SMCs, the number of (pro)renin receptors shows a significant
difference in normal rats (Table 5.). These differences in the
number of (pro)renin receptors were not observed in STZ-
induced diabetic rats. Any other differences in the number of
(pro)renin receptors between the STZ-induced diabetic and
normal rats were not detected (Tables 3 and 4.).The plasma or
tissue levels of angiotensin II did not change in STZ-induced
diabetic rat kidneys (Table 2.).
4.1. The Regulation of (Pro)Renin Receptors in Normal Rats.
The(pro)renin receptorswere localized in glomerularmesan-
gial cells, and in vascular SMCs of renal arteries and coro-
nary arteries. The (pro)renin receptors were also shown by
immunohistochemistry to be in glomerular epithelial cells
and in distal and collecting tubular cells of the kidney [9].
The (pro)renin receptors have enhanced renal expression
in neonates, supporting the hypothesis that the (pro)renin
receptor plays an important role in kidney development [10].
The (pro)renin receptors were positioned on the cell surface
and in parts of cytoplasm [8, 9]. In this study, the number
of (pro)renin receptors was estimated in arteriolar renin-
positive and renin-negative SMCs and endothelial cells. The
immunohistochemical signal was estimated separately for
the surfaces of renin-negative and renin-positive SMCs and
endothelial cells and for the cytoplasm of renin-negative and
renin-positive SMCs. The signals of immunohistochemistry
on membranes of renin vacuoles were also estimated. The
(pro)renin receptors were upregulated on the surface of
renin-positive SMC and downregulated in the cytoplasm of
renin-positive SMCs compared to the renin-negative SMCs.
The regulation of (pro)renin receptors in arterioles of normal
kidneys was related to renin granulation.
4.2. The Regulation of (Pro)Renin Receptors in Diabetic Rats.
The expression of (pro)renin receptors in the nephron is
increased in angiotensin II-dependent hypertension [11]. In
diabetes, (pro)renin expression is also elevated, treatment
with a (pro)renin antagonist, such as handle reagent peptide
(HRP), reversed the development of diabetic nephropathy
[11]. The (pro)renin receptors may regulate renin activ-
ity in the distal nephron during angiotensin II-induced
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Figure 3: (a-b) Immunohistochemical signal was presented on surface and vacuoles of renin-positive SMCs and in cytoplasm of renin-
positive SMCs. About 3000 TEMmicrographs were analyzed for estimating the signal of renin receptors.
Table 4: The number of renin receptors in renin granules and on endothelial surfaces in normal and diabetic rats.
n normal diabetic p
mean (CV)
renin receptor in renin granule of afferent arterioles (signals/𝜇m3) 5 1.47(0.83) 0.79(0.61) NS
renin receptor in endothelia cell surface of afferent arterioles (signals/𝜇m3) 5 0.22(0.71) 0.44(0.53) NS
Table 5: The number of renin receptors on the surface and in the cytoplasm of renin positive and renin negative SMCs.
n surface cytoplasm p
mean (CV)
renin receptor in afferent arterioles renin-positive SMCs (signals/𝜇m3) normal 5 0.66(0.38) 1.3(0.34) 0.01
diabetic 5 1.02(0.68) 0.79(0.61) NS
renin receptor in afferent arterioles renin-negative SMCs (signals/𝜇m3) normal 5 0.34(0.44) 0.62(0.66) NS
diabetic 5 0.61(0.77) 1.09(0.81) NS
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hypertension [12], but it has been shown that the (pro)renin
receptors can act independently of the renin-angiotensin
system. It remains to be determinedwhether (pro)renin is the
true physiologic ligand of (pro)renin receptors [12].
Angiotensin II levels in the kidney are elevated in STZ-
induced diabetes [1, 2, 16] and renin granulation is also
elevated in afferent arterioles [17]. Our recent demonstration
showed that angiotensin II receptor distribution is related to
renin granulation in normal and STZ-induced diabetes [5, 6].
In present the study, similar to our earlier study [6], the
STZ treatment increased blood sugar levels significantly over
10 weeks (Table 1), while the levels of angiotensin II in the
kidney and the plasma were not changed (Table 2). There
were not found any secondary pathomorphological changes
in glomerulus and increments of renin granulation of arte-
rioles. The (pro)renin receptors in our diabetes model were
estimated in this preliminary stage of diabetes.The estimation
of (pro)renin receptors in kidney arterioles showed that the
(pro)renin receptors are redistributed in diabetes compared
to normal. The significant differences in the number of
(pro)renin receptors observed between the renin-positive
and renin-negative SMCs in normal rat kidneys were not
presented in the diabetic sample. These redistributions were
independent of angiotensin II plasma or kidney levels.
5. Conclusion
The distribution of (pro)renin receptors in afferent arteriolar
SMCs is related to renin granulation of SMCs, but indepen-
dent of the angiotensin II plasma or tissue levels in the kidney.
Therefore the (pro)renin receptors could be a possible target
to get the pharmacological effects on renin granulation of
SMCs in kidney arterioles.
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